Structures by: Frampton C. S.
Total: 92
C27H48
C27H48
Crystal Structure Report Archive (2002) 51
a=11.3936(3)Å b=10.8972(3)Å c=19.5047(7)Å
α=90.00° β=104.2390(10)° γ=90.00°
Creatine monohydrate
C4H9N3O2,H2O1
Journal of the Chemical Society, Faraday Transactions (1997) 93, 10 1875-1879
a=12.489(7)Å b=4.987(1)Å c=12.075(6)Å
α=90° β=108.86(3)° γ=90°
Creatine monohydrate
C4H9N3O2,H2O1
J.Chem.Soc.,Faraday Trans. (1997) 93, 1875
a=12.492(4)Å b=4.967(1)Å c=12.051(4)Å
α=90° β=109.10(2)° γ=90°
C33H45N3O2
C33H45N3O2
Organic & biomolecular chemistry (2006) 4, 3 455-461
a=7.626(4)Å b=20.455(4)Å c=19.100(6)Å
α=90° β=93.27(4)° γ=90°
RWX0315/Wilson/NW-G020/5107/25-9-98.
C38H51N3O2
Organic & biomolecular chemistry (2006) 4, 3 455-461
a=15.179(3)Å b=7.728(2)Å c=28.337(6)Å
α=90.00° β=90.00° γ=90.00°
C16H27NO6S
C16H27NO6S
Organic & biomolecular chemistry (2005) 3, 10 1942-1952
a=15.095(1)Å b=10.338(6)Å c=11.718(5)Å
α=90.0000° β=97.582(4)° γ=90.0000°
C14H22O5S
C14H22O5S
Organic & biomolecular chemistry (2005) 3, 10 1942-1952
a=6.8076(9)Å b=9.3008(12)Å c=12.2010(18)Å
α=96.400(8)° β=105.284(9)° γ=92.286(9)°
C12H18NO4S
C12H18NO4S
Organic & biomolecular chemistry (2005) 3, 10 1942-1952
a=10.927(8)Å b=8.372(6)Å c=14.620(10)Å
α=90.00° β=96.444(14)° γ=90.00°
C17H23NO4,0.5(C4H8O2)
C17H23NO4,0.5(C4H8O2)
Organic & biomolecular chemistry (2013) 11, 15 2514-2533
a=16.17422(15)Å b=16.17422(15)Å c=7.32793(11)Å
α=90.00° β=90.00° γ=90.00°
C19H29NO6
C19H29NO6
Organic & biomolecular chemistry (2013) 11, 15 2514-2533
a=10.6847(2)Å b=12.1746(3)Å c=14.6780(3)Å
α=90.00° β=95.328(2)° γ=90.00°
C11H13NO
C11H13NO
Organic & biomolecular chemistry (2013) 11, 15 2514-2533
a=7.192(3)Å b=14.069(4)Å c=9.2117(16)Å
α=90.00° β=102.365(19)° γ=90.00°
03csf003
C23H27NO4
Organic & biomolecular chemistry (2013) 11, 15 2514-2533
a=6.2151(2)Å b=16.8252(5)Å c=9.7311(4)Å
α=90.00° β=90.1760(10)° γ=90.00°
04csf005
C40H47NO7
Organic & biomolecular chemistry (2013) 11, 15 2514-2533
a=10.6749(8)Å b=11.6338(9)Å c=17.3660(11)Å
α=108.132(3)° β=103.266(3)° γ=110.833(4)°
C12H17NO3
C12H17NO3
Organic & biomolecular chemistry (2012) 10, 24 4685-4688
a=5.97836(4)Å b=12.67070(7)Å c=15.76352(9)Å
α=90.00° β=90.00° γ=90.00°
SAW694 IC-1
C12H17N1O3
Organic & biomolecular chemistry (2012) 10, 24 4685-4688
a=7.5034(2)Å b=12.2919(4)Å c=13.0178(4)Å
α=90.00° β=90.00° γ=90.00°
Zopiclone
C17ClN6O3
Chemical communications (Cambridge, England) (2001) 21 2204-2205
a=15.2023(4)Å b=7.1510(1)Å c=17.6577(3)Å
α=90.0° β=111.213(1)° γ=90.0°
Zopiclone dihydrate
C17ClN6O3,2(O)
Chemical communications (Cambridge, England) (2001) 21 2204-2205
a=16.4834(1)Å b=7.1465(1)Å c=17.4026(1)Å
α=90.0° β=109.8065(4)° γ=90.0°
Zopiclone
C17ClN6O3
Chemical communications (Cambridge, England) (2001) 21 2204-2205
a=5.5813(1)Å b=8.8467(1)Å c=35.6588(3)Å
α=90.0° β=90.0° γ=90.0°
Zopiclone
C17H17ClN6O3
Chemical communications (Cambridge, England) (2001) 21 2204-2205
a=5.50540(10)Å b=8.7686(2)Å c=35.5277(7)Å
α=90.00° β=90.00° γ=90.00°
Zopiclone
C17H17ClN6O3
Chemical communications (Cambridge, England) (2001) 21 2204-2205
a=5.50230(10)Å b=8.7676(2)Å c=35.5314(7)Å
α=90.00° β=90.00° γ=90.00°
Zopiclone dihydrate
C17H21ClN6O5
Chemical communications (Cambridge, England) (2001) 21 2204-2205
a=16.374(4)Å b=7.030(3)Å c=17.185(2)Å
α=90° β=108.62(1)° γ=90°
C20H32N2O6
C20H32N2O6
Chemical Communications (1999) 24 2523
a=6.332(4)Å b=26.000(4)Å c=6.720(3)Å
α=90.00° β=112.63(4)° γ=90.00°
JACQ03 Quasiracemate, 4S-Dianins, 2S,4R nor analogue0.33 Tetrachloromethane solvate
C18H20O2,C17H18O2,1/3(CCl4)
CrystEngComm (2017)
a=26.5576(5)Å b=26.5576(5)Å c=11.1274(4)Å
α=90° β=90° γ=120°
7-Methyl Dianin's compound
C19H22O2
CrystEngComm (2017)
a=9.77030(15)Å b=12.02971(18)Å c=12.7860(2)Å
α=90° β=90.6565(14)° γ=90°
JACQ02 Quasiracemate, 2R,4R AND 2R,4S nor methyl analogues0.33 Tetrachloromethane solvate
6(C17H18O2),CCl4
CrystEngComm (2017)
a=26.3307(3)Å b=26.3307(3)Å c=11.1874(3)Å
α=90° β=90° γ=120°
6-Methyl Dianin's compound
C19H22O2
CrystEngComm (2017)
a=14.14913(16)Å b=6.42088(6)Å c=18.3566(2)Å
α=90° β=111.9730(13)° γ=90°
S-Dianin's Compound with IPA guest, Type I cell
((C18H20O1S1),0.33(C3H8O1))
CrystEngComm (2017)
a=28.246(4)Å b=28.246(4)Å c=10.965(3)Å
α=90° β=90° γ=120°
S-Thiadianin's, R-Dianin's IPA Quasiracemate, Type I cell
(C18H20OS),(C18H20O2),0.67(C3H8O)
CrystEngComm (2017)
a=27.6575(15)Å b=27.6575(15)Å c=10.9557(14)Å
α=90° β=90° γ=120°
S-ThiaDianin's Compound 0.33 IPA solvate, Type II cell
((C18H20O1S1),0.33(C3H8O1))
CrystEngComm (2017)
a=56.1623(4)Å b=56.1623(4)Å c=10.88656(12)Å
α=90° β=90° γ=120°
S-ThiaDianin's Compound 0.33 IPA solvate, Type II cell
((C18H20O1S1),0.33(C3H8O1))
CrystEngComm (2017)
a=56.4934(4)Å b=56.4934(4)Å c=10.90410(10)Å
α=90° β=90° γ=120°
S-Thiadianin's, R-Dianin's IPA Quasiracemate, Type II cell
(C18H20OS),(C18H20O2),0.66(C3H8O)
CrystEngComm (2017)
a=55.0808(9)Å b=55.0808(9)Å c=10.8542(2)Å
α=90° β=90° γ=120°
SelenaDianin's Compound 0.33 IPA solvate, Type III cell
((C18H20O1Se1),0.33(C3H8O1))
CrystEngComm (2017)
a=113.983(5)Å b=113.983(5)Å c=10.7937(7)Å
α=90° β=90° γ=120°
S-ThiaDianin's Compound 0.33 IPA solvate, Type III cell
((C18H20O1S1),0.33(C3H8O1))
CrystEngComm (2017)
a=111.7910(4)Å b=111.7910(4)Å c=10.85680(10)Å
α=90° β=90° γ=120°
R-Dianin's Compound
C18H20O2
Chem.Commun. (2013) 49, 7198
a=10.0279(1)Å b=10.4702(1)Å c=13.2012(1)Å
α=90.00° β=90.00° γ=90.00°
S-Thiadianin's, R-Dianin's empty Quasiracemate
C18H20OS,C18H20O2
Chem.Commun. (2013) 49, 7198
a=27.2258(4)Å b=27.2258(4)Å c=10.8365(2)Å
α=90.00° β=90.00° γ=120.00°
S-Thiadianin's, R-Dianin's CCl4,H2O Quasiracemate
3(C18H20OS),3(C18H20O2),(CCl4),0.5(H2O)
Chem.Commun. (2013) 49, 7198
a=27.3283(4)Å b=27.3283(4)Å c=10.8327(3)Å
α=90.00° β=90.00° γ=120.00°
S-ThiaDianin's Compound
C18H20OS
Chem.Commun. (2013) 49, 7198
a=10.5486(1)Å b=10.5395(1)Å c=13.1045(2)Å
α=90.00° β=90.00° γ=90.00°
S-Thiadianin's, R-Dianin's empty Quasiracemate
C18H20OS,C18H20O2
Chem.Commun. (2013) 49, 7198
a=27.2258(4)Å b=27.2258(4)Å c=10.8365(2)Å
α=90.00° β=90.00° γ=120.00°
RWX0225/Wilson/Ref. NW-AO45-1/29-7-96.
C19H23NO2
Journal of the Chemical Society, Perkin Transactions 1 (2000) 9 1363
a=10.1424(14)Å b=16.7857(13)Å c=10.7011(15)Å
α=90.00° β=114.446(9)° γ=90.00°
RWX0315/Wilson/NW-G012/5107/16-7-98.
C20H28N2O
Journal of the Chemical Society, Perkin Transactions 1 (2000) 9 1363
a=16.219(3)Å b=11.966(3)Å c=18.823(3)Å
α=90.00° β=90.00° γ=90.00°
RWX0441/Wilson/NW-G058/5107/24-4-97.
C21H27NO2
Journal of the Chemical Society, Perkin Transactions 1 (2000) 9 1363
a=11.4254(4)Å b=20.1558(6)Å c=16.4936(5)Å
α=90.00° β=99.5060(10)° γ=90.00°
RWX0255/Wilson/NW-C083/5107/24-4-97.
C24H27NO2
Journal of the Chemical Society, Perkin Transactions 1 (2000) 9 1379
a=9.358(2)Å b=11.813(3)Å c=9.917(3)Å
α=90.00° β=114.44(2)° γ=90.00°
CSF93/Spivey/AN-Wafers/4999/12-3-99.
C23H24N2O2
Journal of the Chemical Society, Perkin Transactions 1 (2000) 20 3460
a=5.3697(3)Å b=16.3416(14)Å c=21.7265(18)Å
α=90.00° β=90.00° γ=90.00°
RWX0315/Wilson/NW-F051/5107/16-7-98.
C46H55N3O
Journal of the Chemical Society, Perkin Transactions 1 (2002) 7 901
a=11.350(2)Å b=12.9829(18)Å c=14.928(3)Å
α=71.775(12)° β=79.479(16)° γ=70.577(16)°
RWX0256/Wilson/NW-D003/5107/15-5-97.
C27H34N2O
Journal of the Chemical Society, Perkin Transactions 1 (2002) 7 901
a=14.030(3)Å b=12.956(4)Å c=14.047(3)Å
α=90.00° β=114.457(13)° γ=90.00°
RWX0315/Wilson/NW-C076-2/5107/28-9-98.
C26H29NO2
Journal of the Chemical Society, Perkin Transactions 1 (2002) 7 901
a=7.4893(18)Å b=13.585(4)Å c=11.005(4)Å
α=90.00° β=99.39(2)° γ=90.00°
C21H45N3NiO3,F6P,NO3
C21H45N3NiO3,F6P,NO3
Acta Crystallographica Section B (2006) 62, 2 236-244
a=14.008(2)Å b=14.008(2)Å c=14.008(2)Å
α=90° β=90° γ=90°
HOAt Form I
C5H4N4O
Acta Crystallographica Section B (2006) 62, 4 642-650
a=22.0427(6)Å b=3.93110(10)Å c=14.2340(4)Å
α=90.00° β=114.8850(10)° γ=90.00°
HOAt Form II
C5H4N4O
Acta Crystallographica Section B (2006) 62, 4 642-650
a=3.74870(10)Å b=20.8881(5)Å c=7.0982(2)Å
α=90.00° β=96.2570(10)° γ=90.00°
Carboxine Form I
C12H13NO2S
Acta Crystallographica Section E (2018) 74, 12 1741-1745
a=5.1669(2)Å b=14.0781(5)Å c=15.5152(5)Å
α=82.596(3)° β=80.552(3)° γ=80.463(3)°
Carboxine Form II
C12H13NO2S
Acta Crystallographica Section E (2018) 74, 12 1741-1745
a=9.6424(2)Å b=11.4059(3)Å c=21.6672(5)Å
α=90° β=94.711(2)° γ=90°
(<i>R</i>)-4-(4-Hydroxyphenyl)-2,2,4-trimethylthiachroman-1-oxide, ThiaDianin's sulfoxide
C18H20O2S
Acta Crystallographica Section E (2018) 74, 11 1633-1636
a=10.4311(3)Å b=11.0892(3)Å c=12.8868(3)Å
α=90° β=90° γ=90°
2,4,6,8-Tetrakis(3,5-di-<i>tert</i>-butylphenoxy)pyrimido[5,4-<i>d</i>]pyrimidine
C62H84N4O4
Acta Crystallographica Section E (2019) 75, 3 383-387
a=18.48641(17)Å b=15.84310(14)Å c=39.4611(4)Å
α=90° β=93.0666(8)° γ=90°
Murray <i>N</i>-oxide catalyst
C4H6N2O,H2O
Acta Crystallographica Section E (2017) 73, 3 372-374
a=7.5941(6)Å b=10.0703(6)Å c=7.8286(6)Å
α=90° β=112.402(9)° γ=90°
Pyrimethanil Form 2
C12H13N3
Acta Crystallographica Section E (2017) 73, 6 886-889
a=10.5351(4)Å b=19.1686(7)Å c=22.1162(8)Å
α=90° β=102.778(4)° γ=90°
Equilenin
C18H18O2
Acta Crystallographica Section E (2017) 73, 8 1223-1226
a=7.27709(7)Å b=7.32686(6)Å c=25.5179(2)Å
α=90° β=90° γ=90°
4-(4-Hydroxyphenyl)-2,2,4-trimethyl-7,8-benzothiachroman
C22H22OS
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 11 1662-1665
a=10.3190(3)Å b=20.6009(7)Å c=15.8756(5)Å
α=90° β=91.640(3)° γ=90°
C27H48
C27H48
Acta Crystallographica Section E (2002) 58, 4 o445-o446
a=11.3936(3)Å b=10.8972(3)Å c=19.5047(7)Å
α=90° β=104.2390(11)° γ=90°
S-(ethenyl)-S-phenyl-N-(p-tolylsulfonyl)sulfoximine
C15H15NO3S2
Acta Crystallographica Section C (1998) 54, 9 1335-1341
a=15.8782(11)Å b=5.7840(9)Å c=17.1481(9)Å
α=90.00° β=107.535(4)° γ=90.00°
(E)-S-(propenyl)-S-phenyl-N-(p-tolylsulfonyl)sulfoximine
C16H17NO3S2
Acta Crystallographica Section C (1998) 54, 9 1335-1341
a=35.6712(18)Å b=5.8847(19)Å c=15.4068(15)Å
α=90.00° β=90.737(7)° γ=90.00°
(E)-S-(2-cyclohexylethenyl)-S-phenyl-N-(p-tolylsulfonyl)sulfoximine
C21H25NO3S2
Acta Crystallographica Section C (1998) 54, 9 1335-1341
a=10.370(2)Å b=9.9267(18)Å c=19.9997(16)Å
α=90.00° β=94.285(10)° γ=90.00°
(E)-S-phenyl-S-(4-phenylbut-1-enyl)-N-(p-tolylsulfonyl)sulfoximine
C23H23NO3S2
Acta Crystallographica Section C (1998) 54, 9 1335-1341
a=9.968(3)Å b=11.6851(14)Å c=18.509(4)Å
α=90.00° β=90.00° γ=90.00°
(E)-S-(2-trimethylsilylphenyl)-S-(3-methyl-1-trimethylsilylbut-1-enyl)- N-(p-tolylsulfonyl)sulfoximine
C24H37NO3S2Si2
Acta Crystallographica Section C (1998) 54, 9 1335-1341
a=13.876(7)Å b=21.926(8)Å c=9.363(2)Å
α=97.05(3)° β=91.78(3)° γ=99.83(3)°
(E)-S-(2-trimethylsilylphenyl)-S-(2-phenyl-1-trimethylsilylethenyl)- N-(p-tolylsulfonyl)sulfoximine
C27H35NO3S2Si2
Acta Crystallographica Section C (1998) 54, 9 1335-1341
a=11.142(3)Å b=17.128(4)Å c=15.541(4)Å
α=90.00° β=100.35(3)° γ=90.00°
(E)-S-(1-trimethylsilylprop-1-enyl)-S-phenyl-N-(p-tolylsulfonyl)sulfoximine
C19H25NO3S2Si
Acta Crystallographica Section C (1998) 54, 9 1335-1341
a=11.019(2)Å b=17.093(4)Å c=11.044(3)Å
α=90.00° β=99.73(3)° γ=90.00°
Phenyl vinylsulfone
C8H8O2S
Acta Crystallographica Section C (1998) 54, 9 1335-1341
a=9.747(2)Å b=10.648(2)Å c=15.418(3)Å
α=90.00° β=90.00° γ=90.00°
C4H5NaO4
C4H5NaO4
Acta Crystallographica Section C (1992) 48, 8 1555-1556
a=8.8710(10)Å b=10.2560(10)Å c=7.3450(10)Å
α=90° β=117.270(10)° γ=90°
C4Cl4O2S
C4Cl4O2S
Acta Crystallographica Section C (1993) 49, 6 1197-1199
a=18.204(4)Å b=7.8550(10)Å c=11.751(2)Å
α=90° β=91.77(2)° γ=90°
C12H28N,Cl
C12H28N,Cl
Acta Crystallographica Section C (1995) 51, 11 2432-2434
a=5.682(2)Å b=7.186(6)Å c=17.775(2)Å
α=90° β=92.75(2)° γ=90°
1,1,3,3-tetramethylurea
C5H12N2O
Acta Crystallographica Section C (1996) 52, 12 3246-3248
a=10.6297(10)Å b=6.2597(4)Å c=9.9677(7)Å
α=90.000° β=93.034(7)° γ=90.000°
C4H4N4
C4H4N4
Acta Crystallographica Section C (1996) 52, 5 1218-1220
a=8.444(2)Å b=5.015(2)Å c=12.5573(9)Å
α=90.° β=100.345(9)° γ=90.°
(C11H26N1),(Cl1),(H2O)
(C11H26N1),(Cl1),(H2O)
Acta Crystallographica Section C (1996) 52, 5 1261-1263
a=7.701(2)Å b=40.020(5)Å c=4.6437(6)Å
α=90.° β=107.34(1)° γ=90.°
PH46 (S)-(-)-methylbenzylamine salt
C8H12N,C26H21O3
Acta Crystallographica Section C (2012) 68, 8 o323-o326
a=11.0350(3)Å b=10.1713(3)Å c=11.8533(3)Å
α=90.00° β=93.678(2)° γ=90.00°
Dianin's amine
C18H21NO
Acta Crystallographica Section C (2011) 67, 5 o188-o191
a=10.23394(11)Å b=10.25106(10)Å c=13.47563(13)Å
α=90.00° β=90.00° γ=90.00°
Racemic guest-free Dianin's compound
C18H20O2
Acta Crystallographica Section C (2011) 67, 5 o188-o191
a=26.7321(5)Å b=26.7321(5)Å c=10.8700(3)Å
α=90.00° β=90.00° γ=120.00°
Kga1-101-cp. batch 1
C11H13NO
Acta Crystallographica Section C (2013) 69, 11 1207-1211
a=6.2966(6)Å b=25.416(4)Å c=11.7111(13)Å
α=90.00° β=90.162(8)° γ=90.00°
Carbamazepine-trifluoroacetic acid (1/1)
C15H12N2O1,C2H1F3O2
Acta Crystallographica Section C (2013) 69, 11 1260-1266
a=14.9968(12)Å b=5.2660(3)Å c=20.1911(12)Å
α=90.00° β=102.191(7)° γ=90.00°
Carbamazepine--trifluoroacetic acid (1/1)
C15H12N2O1,C2H1F3O2
Acta Crystallographica Section C (2013) 69, 11 1260-1266
a=14.9970(3)Å b=5.37120(10)Å c=20.4441(4)Å
α=90.00° β=101.529(2)° γ=90.00°
Carbamazepine mesylate
C15H13N2O1,C1H3O3S1
Acta Crystallographica Section C (2013) 69, 11 1260-1266
a=5.5673(7)Å b=15.7196(19)Å c=18.125(2)Å
α=90.00° β=97.641(4)° γ=90.00°
9,10-Dihydrocarbamazepine mesylate
C15H15N2O1,C1H3O3S1
Acta Crystallographica Section C (2013) 69, 11 1260-1266
a=5.4477(2)Å b=15.7340(7)Å c=18.5034(8)Å
α=90.00° β=96.647(4)° γ=90.00°
Hexabenyzlbenzene
C48H42
Acta Crystallographica Section C (2000) 56, 1 e22-e22
a=8.999(2)Å b=10.456(4)Å c=10.622(4)Å
α=69.218(12)° β=79.20(2)° γ=67.07(2)°
Compound 1
C20H22N2S
Acta Crystallographica Section C (2001) 57, 4 431-432
a=19.4661(7)Å b=10.7312(4)Å c=8.3000(3)Å
α=90.00° β=90.00° γ=90.00°
Compound 2
C20H22N2O2S
Acta Crystallographica Section C (2001) 57, 4 431-432
a=18.9551(11)Å b=11.4905(7)Å c=8.1745(4)Å
α=90.00° β=90.00° γ=90.00°
Bis-[(4,4"-didecyloxy-p-terphenyl-2'-yl)methyl]carbonate
C79H110O7
Acta Crystallographica Section C (2000) 56, 4 e156-e156
a=33.654(9)Å b=30.229(8)Å c=6.798(2)Å
α=90.00° β=94.740(10)° γ=90.00°
2,2,4,4-Tetramethyl-1,5-diphenyl-6,7,8-trioxa-3-thiabicyclo[3.2.1]octane
C20H22O3S
Acta Crystallographica Section C (2000) 56, 12 1510-1511
a=6.0507(5)Å b=9.6570(9)Å c=15.4541(14)Å
α=82.093(8)° β=78.738(6)° γ=75.898(5)°
HA-364-1
C41H50N2O7
The Journal of organic chemistry (2016) 81, 20 9947-9956
a=11.2573(5)Å b=11.5352(5)Å c=15.1073(6)Å
α=76.412(4)° β=87.183(4)° γ=80.002(4)°
2,4-dimethoxyphenylphosphaadamantane
C18H25O5P
Journal of Organic Chemistry (2004) 69, 7635-7639
a=8.02170(10)Å b=8.16080(10)Å c=14.4538(2)Å
α=83.4460(10)° β=76.3320(10)° γ=89.2410(10)°
Thiadianin's amine
C18H21NS
Acta Crystallographica Section C (2011) 67, 5 o188-o191
a=10.6043(6)Å b=10.4104(5)Å c=13.4126(6)Å
α=90.00° β=90.00° γ=90.00°
Bis(ferrocenecarboxylato)phthalocyaninato Silicon(IV)
C56H36Cl6Fe2N8O4Si
Inorganic Chemistry (1998) 37, 411-417
a=10.417(6)Å b=21.046(9)Å c=23.130(6)Å
α=90.00° β=94.22(4)° γ=90.00°
Phthalocyaninato bis(undecylcarboxylato)Silicon(IV)
C56H62N8O4Si
Inorganic Chemistry (2001) 40, 5434-5439
a=8.9976(14)Å b=15.522(2)Å c=19.031(2)Å
α=105.797(10)° β=100.621(11)° γ=93.939(12)°
Phthalocyaninato bis(chloro)silicon(IV)
C32H16Cl2N8Si
Inorganic Chemistry (2001) 40, 5434-5439
a=8.997(2)Å b=14.582(4)Å c=10.129(4)Å
α=90.00° β=97.74(3)° γ=90.00°
Phthalocyaninato bis(undecylcarboxylato)Tin(IV)
C56H62N8O4Sn
Inorganic Chemistry (2001) 40, 5434-5439
a=13.206(5)Å b=15.539(4)Å c=12.762(4)Å
α=98.15(3)° β=103.26(3)° γ=100.93(3)°